@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-FG8LP9J8-Q skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-W8MNH2H7-8 skos:prefLabel "Inhibiteurs des canaux calciques"@fr, "Calcium Channel Blockers"@en ; a mesh:Descriptor, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-VJ4ZQC33-K skos:prefLabel "Dihydropyridines"@en, "Dihydropyridines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-RLTL7KBG-H . jvr:-K9FBN5C5-1 skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-RLTL7KBG-H skos:hiddenLabel "PN 205-034"@fr, "PN 205-034"@en, "PN-200-110"@en, "Isradipine, (R)-Isomer"@en, "PN-205-034"@en, "PN 205-033"@en, "PN200-110"@fr, "Isradipine, (S)-Isomer"@en, "Dynacirc"@en, "PN205-034"@fr, "Isradipine, (+-)-Isomer"@en, "PN205034"@fr, "PN205033"@fr, "Lomir"@en, "PN205-033"@fr, "PN-205-033"@fr, "PN-205-033"@en, "PN 200-110"@fr, "PN 200-110"@en, "PN200110"@fr ; mesh:allowableQualifier jvr:-L6C0XPHT-4, jvr:-XV06LPML-W, jvr:-M63HSDM7-1, jvr:-WK5F724J-1, jvr:-HQRFT0C6-B, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-W6SQV79N-S, jvr:-SBNWSM1T-R, jvr:-R0ZCQ8X6-J, jvr:-THHNVC7V-3, jvr:-R3QWLHRG-V, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-G4R176S9-J, jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-CB30NGKB-3, jvr:-BT300B3G-Q, jvr:-NKM836P1-M, jvr:-NB0XHT3S-N, jvr:-G30ZJ446-J, jvr:-Q3979798-W, jvr:-D0F21513-5, jvr:-S0CS1X5R-5 ; mesh:pharmacologicalAction jvr:-K9FBN5C5-1, jvr:-W8MNH2H7-8, jvr:-FG8LP9J8-Q ; skos:altLabel "84260-63-9 ((R)-isomer)"@en, "84260-63-9 ((R)-isomer)"@fr, "84260-64-0 ((S)-isomer)"@en, "84260-64-0 ((S)-isomer)"@fr, "YO1UK1S598"@fr, "YO1UK1S598"@en, "75695-93-1 (Isradipine)"@fr, "75695-93-1 (Isradipine)"@en, "88977-22-4 ((+-)-isomer)"@fr, "88977-22-4 ((+-)-isomer)"@en, "3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester"@fr, "3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester"@en ; dc:created "1992-05-20"^^xsd:date ; a skos:Concept, mesh:Descriptor ; dc:modified "2016-05-31"^^xsd:date ; owl:sameAs ; skos:broader jvr:-VJ4ZQC33-K ; skos:inScheme jvr: ; skos:prefLabel "Isradipine"@en, "Isradipine"@fr ; skos:definition "A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure."@en ; dc:established "1993-01-01"^^xsd:date . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .